Old asthma drug may help kids with rare growth disorder

NCT ID NCT03029429

Summary

This study is testing whether theophylline, a medication long used for asthma, can help manage symptoms of a rare genetic condition called pseudohypoparathyroidism. Researchers are giving the drug to 29 children and young adults with the condition for one year to see if it helps with weight loss, improves blood sugar control, and slows early bone growth plate closure. The goal is to find a new way to control the obesity and growth problems that current hormone treatments don't address.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSEUDOHYPOPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ashley Shoemaker

    Nashville, Tennessee, 37212, United States

Conditions

Explore the condition pages connected to this study.